Mueller T, Hughes D C, Patel M V. "一种的合成方法" [P]. US Patent, US 11707267 B2, 2020-03-09.
发明人马晓峰,朱建伟,唐晓军. "Method for the Synthesis of 4-(3-Methoxy-3-oxo-1-(1-oxoisoindolin-2-yl)propyl)phenyl furan-2-carboxylate" [P]. 中国发明专利, 专利号 CN 111090551 B, 授权公告日 2019-10-19.
发明人黄志刚,胡光,何建平. "A Process for Preparing High-Purity 4-(3-Methoxy-3-oxo-1-(1-oxoisoindolin-2-yl)propyl)phenyl furan-2-carboxylate" [P]. 中国发明专利, 专利号 CN 110603297 A, 授权公告日 2018-10-11.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2014, 330, (3), 7910-7930.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Nat. Prod., 2011, 731, 8401-8411.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 4-(3-Methoxy-3-oxo-1-(1-oxoisoindolin-2-yl)propyl)phenyl furan-2-carboxylate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2015, 948, (8), 9644-9670.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2015, 2060, (8), 5276-5289.